Grant: Engage Grants Program
University of Waterloo
$25,000.00
Development of novel membrane-based SPR biosensing technology
FY 2016-17
Summary
Biosensors are analytical devices, consisting of immobilized biological molecules (bioreceptors), which bind specifically to target analyte molecules1; a biochemical signal is then converted to an electric signal by a transducer. Biosensors have become extremely important in our lives. They are widely used in medical diagnostics, as safety control systems for environment and food, and military defense. Biosensing is currently a vast and vibrant international research enterprise as scientists and engineers strive to develop new technologies to improve the specificity, the speed and the cost of diagnostic tools. With the tremendous progress in nanotechnology, biosensor development is becoming an important and exciting emerging technology combining advanced nanotechnologies with the fundamentals of biological recognition with the purpose of developing new biomedical applications. We propose a new collaboration between a commercial company Nicoya Lifesciences, who developed novel nanotechnology-based biosensing device, Open SPR system, and an academic research group lead by Prof Leonenko, with the purpose of developing new biosensing platforms for studying binding of various biomolecules, proteins and drugs to lipid and cellular membrane. This will advance commercial biosensors technology and will increase the range of biosensing approaches and applications used in health and pharmaceutical industries and other biotechnologies.
Program
Engage Grants Program
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
493709-2016
Name nom
Leonenko, Zoya
Department département
Physics and Astronomy
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2016
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Partie
1
Nb partie
1
Application title
Development of novel membrane-based SPR biosensing technology
Keyword
NSERC
Application summary
Biosensors are analytical devices, consisting of immobilized biological molecules (bioreceptors), which bind specifically to target analyte molecules1; a biochemical signal is then converted to an electric signal by a transducer. Biosensors have become extremely important in our lives. They are widely used in medical diagnostics, as safety control systems for environment and food, and military defense. Biosensing is currently a vast and vibrant international research enterprise as scientists and engineers strive to develop new technologies to improve the specificity, the speed and the cost of diagnostic tools. With the tremendous progress in nanotechnology, biosensor development is becoming an important and exciting emerging technology combining advanced nanotechnologies with the fundamentals of biological recognition with the purpose of developing new biomedical applications. We propose a new collaboration between a commercial company Nicoya Lifesciences, who developed novel nanotechnology-based biosensing device, Open SPR system, and an academic research group lead by Prof Leonenko, with the purpose of developing new biosensing platforms for studying binding of various biomolecules, proteins and drugs to lipid and cellular membrane. This will advance commercial biosensors technology and will increase the range of biosensing approaches and applications used in health and pharmaceutical industries and other biotechnologies.